No tolerance for Pseudomonas in lung transplants
- 5 February 2025
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (784) , eadu6563
Abstract
Pseudomonas infection after lung transplantation induces acute intragraft lymphocytotoxicity that promotes antibody-mediated rejection in mice (Liao et al. , this issue).Keywords
This publication has 9 references indexed in Scilit:
- Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejectionScience Translational Medicine, 2025
- Lung TransplantationNew England Journal of Medicine, 2024
- Single-cell transcriptome mapping identifies a local, innate B cell population driving chronic rejection after lung transplantationJCI Insight, 2022
- B cell‐intrinsic MyD88 signaling controls IFN‐γ‐mediated early IgG2c class switching in mice in response to a particulate adjuvantEuropean Journal of Immunology, 2019
- Type I interferon induces CXCL13 to support ectopic germinal center formationJournal of Experimental Medicine, 2019
- Bronchus-associated lymphoid tissue–resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejectionJournal of Clinical Investigation, 2018
- Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2016
- A Sorting Platform Determines the Order of Protein Secretion in Bacterial Type III SystemsScience, 2011
- Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunityNature Medicine, 2004